港股異動丨匯聚科技復牌大跌14.43% 控股股東羅仲煒正與第三方完成涉公司權益的建議交易條款
格隆匯2月7日丨匯聚科技(01729.HK)復牌大跌14.43%,報0.83港元,總市值15億港元。匯聚科技今早發佈公告,董事會注意到2022年1月31日公司股份價格及交易量出現上漲的情況。公司已作出查詢並瞭解到,其控股股東羅仲煒先生正在與獨立第三方完成涉及羅先生於公司權益的建議交易的條款,該交易一旦進行,將具有收購守則下的涵義。於該公告日期,羅先生間接持有13.8億股股份,相當於公司全部已發行股本約74.67%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.